Delivery Order SPE2DB22D1106-SPE2DB24FEZZ1
Award Date
7/1/24
Potential Completion Date
7/2/24
Potential Value
$7.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,564,359,392 units of the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM. The $1,937.74 Firm Fixed Price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 23, 2024. This award is not associated with a set-aside program. Amerisourcebergen, one of the largest pharmaceutical distribution companies...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of a pharmaceutical product, Fluticasone Prop HFA 220 MCG 12GM, to the U.S. government. The contract is a Delivery Order with a Firm Fixed Price of $4,613.45 and an ultimate completion date of April 30, 2024. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distribution company,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,571.49 for the supply of Fluticasone Prop HFA 110 MCG 12GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of August 9, 2024. The contract is a Firm Fixed Price arrangement. Amerisourcebergen is supplying this pharmaceutical product as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $6,599.63 for the supply of Fluticasone Prop HFA 220 MCG 12GM. The contract was awarded by the Defense Logistics Agency (DLA), with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of December 23, 2024. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,627,166 units of the pharmaceutical product FLUTICASONE PROP HFA 220 MCG 12GM. The $1,685.25 firm fixed price contract was issued by the Defense Logistics Agency (DLA), a defense agency, and has a May 17, 2024 completion date. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to deliver a range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,830,242 units of the pharmaceutical product FLUTICASONE PROP HFA 110 MCG 12GM. The $1,356.97 firm fixed-price delivery order was awarded by the Defense Logistics Agency, a component of the Department of Defense. This contract does not have a set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distribution companies in the world, has a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,337.37 firm fixed-price delivery order is for the supply of 4,566,692,553 units of Fluticasone Prop HFA 220 MCG 12GM, a prescription pharmaceutical product. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product "FLUTICASONE PROP HFA 44 MCG 10.6GM." The contract, valued at $1,368.96, is a firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA), a defense agency. The award has no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM. The contract, valued at $1,016.36, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $3,562.28 firm fixed price delivery order for the supply of the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...